Home / Stocks / CCRN

Cross Country Healthcare (CCRN, —) Stock Valuation & Fair Value Significantly overvalued

Cross Country Healthcare (CCRN, —) trades at a blended P/E of 144.7, about 139% above its historical normal valuation, with a forward growth estimate of 76.8% and a PEG of 1.88. Analysts' one-year estimates have been hit 9% of the time.

No quality score is published for this company, which is normal for insurers, banks and REITs. This rating reflects valuation, forecast return and analyst accuracy only. Ratings that cite business quality require one.

DATA AS OF 2026-09-21
Blended P/E
144.7
Normal P/E
60.6
PEG
1.88
Fwd growth
76.8%
Div yield
0.0%
RSI (14)
—

Valuation flags

Verdict history

tickerseer's rating has been significantly overvalued since 2026-07-31.

Blended P/E and rating by weekBlended P/E moved from 198.3 to 144.7 between 2026-07-31 and 2026-09-21, against a normal P/E of 60.6, with 0 rating changes over 18 recorded weeks.2026-07-31: P/E 198.3, Significantly overvalued (recalculated)2026-08-03: P/E 226.3, Significantly overvalued2026-08-07: P/E 226.3, Significantly overvalued (recalculated)2026-08-10: P/E 226.3, Significantly overvalued2026-08-14: P/E 226.3, Significantly overvalued (recalculated)2026-08-17: P/E 176.5, Significantly overvalued2026-08-21: P/E 176.5, Significantly overvalued (recalculated)2026-08-24: P/E 144.7, Significantly overvalued2026-08-27: P/E 144.7, Significantly overvalued (recalculated)2026-08-28: P/E 144.7, Significantly overvalued (recalculated)2026-08-30: P/E 144.7, Significantly overvalued (recalculated)2026-08-31: P/E 144.7, Significantly overvalued2026-09-05: P/E 144.7, Significantly overvalued (recalculated)2026-09-07: P/E 144.7, Significantly overvalued2026-09-12: P/E 144.7, Significantly overvalued (recalculated)2026-09-14: P/E 144.7, Significantly overvalued2026-09-19: P/E 144.7, Significantly overvalued (recalculated)2026-09-21: P/E 144.7, Significantly overvalued100.0150.0200.0Jul 31Aug 13Aug 26Sep 8Sep 21Normal P/E 60.6
Attractively valuedFairly valuedAbove fair valueLarger dot: a stronger reading

Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.

Selected weeks: the first, the latest, and the cheapest and dearest.

WeekBlended P/EPremium to normal P/ERating
2026-07-31P/E 198.3+227%Significantly overvalued
2026-08-03P/E 226.3+274%Significantly overvalued
2026-08-24P/E 144.7+139%Significantly overvalued
2026-09-21P/E 144.7+139%Significantly overvalued ← now

Frequently asked questions

Is Cross Country Healthcare stock overvalued?

At a blended P/E of 144.7 versus its historical normal P/E of 60.6, Cross Country Healthcare trades about 139% above its typical valuation, with a PEG of 1.88 on 76.8% forward growth. tickerseer currently rates it significantly overvalued.

What is Cross Country Healthcare's fair value and PEG?

Cross Country Healthcare trades at a blended P/E of 144.7 against a historical normal P/E of 60.6, a PEG of 1.88, and a forward growth estimate of 76.8%.

Has tickerseer's rating of Cross Country Healthcare changed?

tickerseer's rating has been significantly overvalued since 2026-07-31.

Industry: —. Create a free account to see the full analysis: the SeerAI score, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.

See the full analysis →🔔 Track CCRN free: valuation & earnings alerts

Get the free weekly earnings preview

One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.

It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.